About Genalyte
Genalyte is a Healthcare company based in San Diego (United States) founded in 2007. Silicon photonics-based multiplexing tools for biomolecular detection are developed. Genalyte has raised $141.8 million across 7 funding rounds from investors including Samsara, Verily and Khosla Ventures. The company has 113 employees. Genalyte has completed 1 acquisition, including BaseHealth. Genalyte offers products and services including Merlin. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is GENALYTE, INC. Its competitors include Enumera Molecular and Radiolife; 1 of its 2 listed competitors has raised funding.
Company details
Genalyte was founded in 2007 in San Diego, United States, focusing on biotechnology for clinical and life science applications. Next-generation multiplexing technology is developed and commercialized, utilizing silicon chip manufacturing for immunodetection. The Maverick platform employs silicon photonics to measure antibody-antigen binding and nucleic acid hybridization. Instruments support autoimmune disease monitoring, cancer biomarker screening, infectious agent testing, and anti-drug antibody detection, with the first launch occurring in 2012.
- Headquarters San Diego, United States
- Employees 113
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website genalyte.com
- Social LinkedIn X
- Legal Name Genalyte, Inc.
- Total Equity Funding$141.8M (USD)
in 7 rounds
- Latest Funding Round$50M (USD), Series E
Jan 2021
- InvestorsSamsara
& 11 more
- Employee Count113
- Investments & Acquisitions
Products & Services of Genalyte
Genalyte offers a comprehensive portfolio of products and services, including Merlin.
Device for rapid automated lab testing with real-time results.
Funding Insights of Genalyte
Genalyte has successfully raised a total of $141.8M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $50 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $141.8M
- Total Rounds 7
- Last Round Series E — $50M
- First Round $11.8M
(Mar 2012)
- Investors Count 12
All 7 funding rounds of Genalyte with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $50M | Series E | – | Verily | |
| Nov 2016 | $36M | Series D | – | Khosla Ventures, Redmile Group | – |
| Aug 2015 | $44M | Series C | – | Khosla Ventures | |
| Jun 2013 | $1M | Grant | – | – | |
| Dec 2012 | $500,000 | Grant | – | – | |
| Sep 2012 | $523,479 | Grant | – | – | |
| Mar 2012 | $11.8M | Series B | – | Redmile Group, Claremont Creek Ventures | – |
12 investors in total: 12 institutional.
Investors in Genalyte
Genalyte has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include Samsara, Verily and Khosla Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage startups are funded by this venture capital firm. | 2004 | khoslaventures.com | Menlo Park, United States | |
Late-stage life sciences investments are managed via VC and PE. | hbmpartners.com | Zug, Switzerland | ||
Seed and early-stage venture capital firm investing in digital solutions for healthcare and energy industries. | claremontcreek.com | |||
Investment management services are provided focusing on healthcare innovation. | puravidainvestments.com | New York, United States | ||
AI-based solutions for health management are provided. | 2015 | verily.com | Dallas, United States | |
Offers financial advisory services including planning, analysis, and wealth management. | 2016 | proveniogroup.org | Bengaluru, India | |
Operates as an employee-owned hedge fund focused on long/short equity strategies. | 2007 | redmilegroup.com | San Francisco, United States | |
AI-powered cloud-based vehicle tracking solutions are offered for fleet owners. | 2015 | samsara.com | San Francisco, United States | |
| biomedventures.tcc.mode | ||||
Cancer research is conducted and supported by the institute. | cancer.gov | Bethesda, United States |
Investor details for Genalyte
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Genalyte
33 people are tracked at Genalyte (10 in leadership, 6 in board & advisors, 17 in team); the tracked headcount is 113.
| Name | Role | Group |
|---|---|---|
Nikki Davis | Director, Laboratory Operations | Leadership |
Ashraf Hanna | Chief Executive Officer | Leadership |
Lewis Marshall | Senior Director Of Hardware Engineering | Leadership |
Rufus Burlingame | VP Clinical Assay Development | Leadership |
Ashleigh Wenz | Executive Assistant To Chief Executive Officer | Leadership |
Sam Rutten | VP of Finance & People Operations | Leadership |
Kevan Samiee | Chief Technology Officer | Leadership |
Iain Clarke | Sr. Director Of Engineering | Leadership |
Dmitriy Lyubskiy | VP Of Software Engineering | Leadership |
Alexah Boyer | Director of Communications & Government Affairs | Leadership |
Cary Gunn | Founder | Board & advisors |
Jeff Huber | Chairman | Board & advisors |
Rajesh Swaminathan | Board Member | Board & advisors |
Saeid Akhtari | Board Member | Board & advisors |
Andrew Conrad | Board Member | Board & advisors |
Rami El Assal | Director | Board & advisors |
Alexandra Osorio | Technology Development Manager | Team |
Juan Lorenzo Hinojosa Hernandez | Full Stack Engineer | Team |
DonnaMae J. | Senior Manufacturing Team Lead | Team |
Jue Wang | Scientist | Team |
13 more people are available in the full profile.
Complete people profiles for Genalyte
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genalyte
Genalyte has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BaseHealth.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Genomics-driven personalized health risks and recommendations are provided. | basehealth.com | Redwood, United States | 2011 | Mar 2020 | •••• |
Complete acquisition details for Genalyte
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Genalyte
4 dated milestones of Genalyte across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Genalyte is founded.
- Funding First funding round of $11.8M.
- Acquisition Acquires BaseHealth.
- Funding Latest funding round, Series E, of $50.0M.
Competitors of Genalyte
Genalyte has 2 listed competitors in our database, 1 of them funded. They include Enumera Molecular and Radiolife.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enumeramolecular.com | 2022 | Ann Arbor, United States | $18.72M | Liquid biopsy tools are developed for biomolecule assessment. | ||
| radiolifelabs.com | 2021 | Wilmington, United States | AI and radio-frequency signatures are used for diagnostics and therapeutics. |
Detailed competitors of Genalyte
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Genalyte
The website of Genalyte (genalyte.com) receives about 3.2K visits a month and ranks #5,689,623 among all websites worldwide, #6,200 in Biotechnology and Pharmaceuticals.
- Monthly visits3.2K
▲ 14.5% vs previous month
- Unique visitors1.2K
per month
- Global rank#5,689,623
among all websites
- Category rank#6,200
Health · Biotechnology and Pharmaceuticals
- Bounce rate51%
- Pages per visit1.9
- Average visit1 min 30 sec
- DevicesDesktop 56% · Mobile 44%
Websites whose visitors overlap most with Genalyte. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
biogeek.com | biogeek.com | 100% | – | ||
immunologyinfo.weebly.com | immunologyinfo.weebly.com | 68% | – | ||
allergiesandyourgut.com | allergiesandyourgut.com | 56% | – | ||
| brainimmune.com | 55% | 2.2K | #7,586,176 | View details | |
patienttalk.org | patienttalk.org | 55% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Genalyte
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Genalyte (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genalyte
Complete news archive for Genalyte
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genalyte
Genalyte was founded in 2007 and raised its 1st funding round 5 years after it was founded.
Genalyte is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Genalyte is a funded company, having raised a total of $141.8M across 7 funding rounds to date. The company's 1st funding round was a Series B of $11.8M, raised on Mar 2012.
Genalyte has 113 employees.
Genalyte was founded in 2007 in San Diego, United States, focusing on biotechnology for clinical and life science applications. Next-generation multiplexing technology is developed and commercialized, utilizing silicon chip manufacturing for immunodetection. The Maverick platform employs silicon photonics to measure antibody-antigen binding and nucleic acid hybridization. Instruments support autoimmune disease monitoring, cancer biomarker screening, infectious agent testing, and anti-drug antibody detection, with the first launch occurring in 2012.
Genalyte's top competitors include Enumera Molecular and Radiolife.
Genalyte offers Merlin.
Genalyte has made 1 acquisition, including BaseHealth.
Genalyte has 12 investors. Key investors include Samsara, Verily, Khosla Ventures, HHS, and National Cancer Institute.
Genalyte operates through Genalyte, Inc..